All Things RSV mAb
This blog entry provides a quick review of the impact of RSV prevention efforts.
mRNA Vaccines Are Here to Stay: Debunking Myths and False Information
This blog entry provides an overview of the history and future of mRNA vaccines.
The FDA’s New Adverse Event Monitoring System (AEMS) Database
This blog entry provides an overview of the U.S. Food and Drug Administration (FDA) new platform, the FDA Adverse Event Monitoring System (AEMS).
Discerning “Good” Research
This blog entry provides information and tips on determining if an article is credible and reputable.
Cervical Cancer Incidence Pre- vs. Post-HPV Vaccination Eras
This blog entry provides a quick synopsis of a new study looking at state-level variance in declines in cervical cancer compared to HPV vaccination rates.
What to Know About One-dose HPV Vaccination
This blog entry discusses the recommended HPV dose schedule for children and adolescents.
Trust In Vaccines—Don’t Believe Everything You Hear
This blog entry includes a summary of a recent poll from Kaiser Family Foundation (KFF) on recent changes to the childhood vaccine schedule.
Provider Liability Concerns with Changes to the CDC Childhood Immunization Schedule
This blog entry includes a summary of the talking points from “Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians,” published in JAMA.
Birthing Institutions and the Vaccines for Children Program
This handout outlines how birthing institution participation in VFC can ensure equitable access to vaccines, save money, and protect newborns from RSV and hepatitis B.
What’s Happening with Aluminum?
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.